期刊文献+

中西医结合治疗晚期结直肠癌不良反应临床观察 被引量:1

The clinical adverse reactions of cooperation of Chinese and western medicine treatment for advanced colorectal cancer
下载PDF
导出
摘要 目的探讨中西医结合治疗晚期结直肠癌临床不良反应。方法选取40例晚期结直肠癌术后患者,随机分为治疗组和对照组各20例。治疗组给予中药联合奥沙利铂+亚叶酸钙+氟尿嘧啶化疗方案治疗,对照组单纯给予化疗方案治疗,比较2组患者临床不良反应发生情况。结果治疗组血液学和胃肠道不良反应发生率均低于对照组,2组比较差异均有统计学意义(P<0.05)。结论晚期结直肠癌术后给予中西医结合治疗可有效降低血液学和胃肠道不良反应。 Objective To explore the clinical adverse reactions of cooperation of Chinese and western medicine treatment for advanced colorectal cancer. Methods 40 cases of postoperative patients with advanced colorectal cancer,were randomly divided into treatment group and control group,the treatment group and control group of 20 cases of 20 cases. Treatment group was given traditional Chinese medicine in combination with oxaliplatin + leucovorin calcium + fluorouracil,the control group,simply giving oxaliplatin + leucovorin calcium + fluorouracil. comparing the clinical adverse reactions of two groups. Results The treatment group of hematology and incidence of gastrointestinal adverse reactions are lower than the control group,the difference was statistically significant( P 〈 0. 05). Conclusion In the treatment for advanced colorectal cancer,combining traditional Chinese and western medicine therapy can effectively reduce the hematology and gastrointestinal adverse reactions.
出处 《临床合理用药杂志》 2016年第5期9-10,共2页 Chinese Journal of Clinical Rational Drug Use
关键词 中西医结合 晚期结直肠癌 不良反应 combine traditional Chinese and western medicine Advanced colorectal cancer Clinical adverse reactions
  • 相关文献

参考文献2

二级参考文献11

  • 1American Cancer Society. Cancer Facts & Figures 2009[ M ]. Atlanta: American Cancer Society, 2009 : 12-13.
  • 2De Paolie A. Innocente R, Buonadonna A, et al. Neoadjuvant therapy of rectal cancer : New treatment perspectives [J ]. Tumori, 2004, 90(4): 373-378.
  • 3Kapiteijn E, Marijnen CA, Nagtegal ID, et al. Preoperative radiotherapy combined with total wesorectal excision for resectable rectal cancer[J]. N Engl J Med, 2001, 345(9): 638-646.
  • 4Camma C, Giunta M, Fiorica F, et al. Preoperative radiotherapy for resectable rectal cancer: a meta-analysis [J]. JAMA ,2000, 284:1008-1015.
  • 5Adam R, Delvart V, Pascal G, et al.Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival [J].Ann Surg,2004,240(4): 644 - 657.
  • 6Li e vre A, Bachet JB, Boige V, et al. KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab [J]. J Clin Oncol, 2008, 26: 374-379.
  • 7Tjandra JJ, Kilkenny JW, Buie WD, et al. Practice parameters for the management of rectal cancer (revised) [J]. Dis Colon Rectum, 2005, 48(3): 411-423.
  • 8Georgiou P, Tan E, Gouvas N, et al. Extended lymphadenectomy versus conventional surgery for rectal cancer: a recta-analysis [J]. Lancet Oncol, 2009, 10(11):1053-1062.
  • 9Segelman J, Singnomklao T, Hellborg H, et al.Differenees in muhidisciplinary team assessment and treatment between patients with stage Ⅳ colon and rectal cancer. Colorectal Dis [J ]. 2009, 11(7):768-774.
  • 10王锡山.直肠癌选择性扩大根治术的可行性[J].中国实用外科杂志,2008,28(12):1032-1034. 被引量:5

共引文献58

同被引文献33

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部